Search hospitals
>
New York
>
Commack
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Claim this profile
Commack, New York 11725
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Smoking
Conducts research for MEK2 Gene Mutation
Conducts research for MEK1 Gene Mutation
6 reported clinical trials
3 medical researchers
Summary
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a medical facility located in Commack, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Smoking, MEK2 Gene Mutation, MEK1 Gene Mutation and other specialties. Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is involved with conducting 6 clinical trials across 12 conditions. There are 3 research doctors associated with this hospital, such as Paul Paik, Yelena Janjigian, MD, and Audree Tadros, MD.
Area of expertise
Breast Cancer
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has run 2 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has run 1 trial for Lung Cancer. Some of their research focus areas include:
Top PIs
Paul Paik
Memorial Sloan Kettering Westchester (All Protocol Activities)
5 years of reported clinical research
Yelena Janjigian, MD
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
6 years of reported clinical research
Audree Tadros, MD
Memorial Sloan Kettering Cancer Center
3 years of reported clinical research
Clinical Trials running at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Lung Cancer
Breast Cancer
Esophageal Cancer
Cushing's Disease
Cushing's Syndrome
Stomach Cancer
Breast cancer
Hypercortisolism
Certolizumab + Chemotherapy + Nivolumab
for Lung Cancer
The purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the usual treatment approach is better than, the same as, or worse than the usual approach alone.
Recruiting
1 award
Phase 2
14 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)?
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a medical facility located in Commack, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Smoking, MEK2 Gene Mutation, MEK1 Gene Mutation and other specialties. Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is involved with conducting 6 clinical trials across 12 conditions. There are 3 research doctors associated with this hospital, such as Paul Paik, Yelena Janjigian, MD, and Audree Tadros, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.